Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 5/20 | 0.50 |
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.50 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.49 |
| ▸ | PGR | P06401 | 5/20 | 0.48 |
| ▸ | IL1RN | P18510 | 1/20 | 0.48 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10325170 | 0.98 | KMT2A (0.52) | KMT2AMEN1CA1CA2CA9 | |
| SCHEMBL8762798 | 0.88 | CA2 (0.56) | KMT2AMEN1CA1CA2CA9 | |
| SCHEMBL28166872 | 0.87 | KEAP1 (0.56) | KMT2AMEN1CA1CA2CA9 | |
| SCHEMBL14582134 | 0.82 | NPSR1 (0.49) | KMT2AMEN1SLC40A1ALDH1A1HPGD | |
| SCHEMBL3673727 | 0.81 | SMN1; SMN2 (0.60) | KMT2AMEN1CA1CA2CA9 | |
| SCHEMBL3683057 | 0.81 | GAA (0.60) | KMT2AMEN1CA1CA2CA9 | |
| SCHEMBL2016598 | 0.79 | KEAP1 (0.56) | KMT2AMEN1CA1CA2CA9 | |
| SCHEMBL10736241 | 0.76 | KMT2A (0.60) | KMT2AMEN1CA1CA2CA9 | |
| SCHEMBL20768536 | 0.76 | KMT2A (0.60) | KMT2AMEN1CA1CA2CA9 | |
| SCHEMBL4805555 | 0.76 | KMT2A (0.55) | KMT2AMEN1CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060252645-A1 | Method for producing material containing sensitizer dispersed therein for thermal recording article an thermal recording article | SANKO CO., LTD. (JP) | 2006-11-09 | — | — | US | claimed |
| EP-1645430-A1 | METHOD FOR PRODUCING MATERIAL CONTAINING SENSITIZER DISPERSED THEREIN FOR THERMAL RECORDING ARTICLE AND THERMAL RECORDING ARTICLE | Sanko Co., Ltd. (JP) | 2006-04-12 | — | — | EP | claimed |
| CN-1738928-A | Compositions for copper, tantalum and tantalum nitride chemical mechanical method complanation | HONEYWELL INT INC (US) | 2006-02-22 | — | — | CN | claimed |
| CN-1382305-A | Compositions and methods for spin etch planarization | ALLIED SIGNAL INC (US) | 2002-11-27 | — | — | CN | claimed |
| CN-106222752-B | A method of preparing organic crystal film | 上海理工大学 | 2019-02-15 | — | — | CN | disclosed |
| EP-2889149-B1 | SENSITIZER PARTICLE DISPERSION FOR THERMOSENSITIVE RECORDING MEDIUM COMPOSED MAINLY OF STEARIC ACID AMIDE, PREPARATION METHOD THEREOF, MIXED DISPERSION COMPOSITION FOR THERMOSENSITIVE RECORDING LAYER, AND THERMOSENSITIVE RECORDING MEDIUM | SANKO CO LTD (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-9375966-B2 | Sensitizer particle dispersion for thermosensitive recording medium composed mainly of stearic acid amide, preparation method thereof, mixed dispersion composition for thermosensitive recording layer, and thermosensitive recording medium | SANKO CO., LTD. (JP) | 2016-06-28 | — | — | US | disclosed |
| US-20150183252-A1 | SENSITIZER PARTICLE DISPERSION FOR THERMOSENSITIVE RECORDING MEDIUM COMPOSED MAINLY OF STEARIC ACID AMIDE, PREPARATION METHOD THEREOF, MIXED DISPERSION COMPOSITION FOR THERMOSENSITIVE RECORDING LAYER, AND THERMOSENSITIVE RECORDING MEDIUM | SANKO CO., LTD. (JP) | 2015-07-02 | — | — | US | disclosed |
| EP-2889149-A1 | SENSITIZER PARTICLE DISPERSION FOR THERMOSENSITIVE RECORDING MEDIUM COMPOSED MAINLY OF STEARIC ACID AMIDE, PREPARATION METHOD THEREOF, MIXED DISPERSION COMPOSITION FOR THERMOSENSITIVE RECORDING LAYER, AND THERMOSENSITIVE RECORDING MEDIUM | Sanko Co., Ltd. (JP) | 2015-07-01 | — | — | EP | disclosed |
| EP-1645430-B1 | METHOD FOR PRODUCING MATERIAL CONTAINING SENSITIZER DISPERSED THEREIN FOR HEAT-SENSITIVE RECORDING MATERIAL | SANKO CO LTD (JP) | 2011-11-30 | — | — | EP | disclosed |
| EP-1431293-B1 | WATER-SOLUBLE PHENYLPYRIDAZINE DERIVATIVES AND DRUGS CONTAINING THE SAME | KOWA CO (JP) | 2011-06-08 | — | — | EP | disclosed |
| US-20090270399-A1 | NOVEL PYRIDAZINE DERIVATIVES AND MEDICINES CONTAINING THE SAME AS EFFECTIVE INGREDIENTS | KOWA CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| CN-1341103-A | Pyridazin-3-one derivatives and drugs containing the same | KOWA CO (JP) | 2002-03-20 | — | — | CN | disclosed |
| US-6348468-B1 | THESE COMPOUNDS HAVE EXCELLENT INHIBITORY ACTIVITY AGAINST INTERLEUKIN-1.BETA. PRODUCTION, IMMUNE SYSTEM DISEASES, INFLAMMATORY DISEASES, ISCHEMIC DISEASES AND THE LIKE. | KOWA CO., LTD. (JP) | 2002-02-19 | — | — | US | disclosed |
| EP-1156039-A1 | PYRIDAZIN-3-ONE DERIVATIVES AND MEDICINES CONTAINING THE SAME | Kowa Co., Ltd. (JP) | 2001-11-21 | — | — | EP | disclosed |
| EP-1061077-A1 | NOVEL PYRIDAZINE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | Kowa Co., Ltd. (JP) | 2000-12-20 | — | — | EP | disclosed |
| EP-1043317-A1 | NOVEL PYRIDAZINE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | Kowa Co., Ltd. (JP) | 2000-10-11 | — | — | EP | disclosed |
| EP-0427929-A2 | Heat-sensitive recording material | MITSUBISHI PAPER MILLS, LTD. (JP) | 1991-05-22 | — | — | EP | disclosed |
| EP-0032625-A2 | Water-soluble monoazo dyes | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-07-29 | — | — | EP | disclosed |
| US-3957553-A | CHELATE COMPOUNDS, OXIDIZERS, 1A HYDROXIDES | PENNWALT CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270399-A1 | NOVEL PYRIDAZINE DERIVATIVES AND MEDICINES CONTAINING THE SAME AS EFFECTIVE INGREDIENTS | IL1B, IL1R1, TLR1 | KMT2A 3265/4885MEN1 4730/4885CA1 4799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.